Showing results (551-560 of 1,383) with videos related to
Sort By:
Pageof 139
ACS Pharmacology & Translational Science|September 19, 2025
Insights into the Expression, Structure, and Function of the Thromboxane A2 Receptor in Vascular BiologyRobert Eckenstaler, Ralf A BenndorfACS Pharmacology & Translational Science|September 19, 2025
Intrinsically Disordered Regions of Zinc Finger Protein 687 in Phase Separation: A Potentially Pathogenic Driver of Paget's Disease of BoneJing Wang, Zheng Guo, Muqing Zhang, et al.ACS Pharmacology & Translational Science|May 15, 2025
Imaging of Microtubules in a Nonhuman Primate Model of Alcohol Use DisorderNaresh Damuka, Mack D Miller, Ivan Krizan, et al.ACS Pharmacology & Translational Science|May 15, 2025
Investigations of Enteric-Coated Tablet Propyl Gallate-Induced Nephrotoxicity in Beagles as well as Human and Dog Renal Proximal Tubule Epithelial CellsSi Mou, B Timothy Hummer, Jiaqi Yuan, et al.ACS Pharmacology & Translational Science|May 15, 2025
5,7-Dimethoxychroman-3-yl 4-methoxybenzoate Has a Unique Effect upon the Modulation of Mutant Cardiac Muscle Thin Filament Function and Dynamics due to Phosphorylation of Troponin IZeyu Yang, Alice M Sheehan, Mary Papadaki, et al.ACS Pharmacology & Translational Science|May 15, 2025
Discovery of SARS-CoV-2 Nsp14-Methyltransferase (MTase) Inhibitors by Harnessing Scaffold-Centric Exploration of the Ultra Large Chemical SpaceSourav Pal, Quinlin M Hanson, Sarah C Ogden, et al.ACS Pharmacology & Translational Science|July 17, 2025
Sigma‑2 Receptor/Transmembrane Protein 97 in Pain Modulation: Tracing Historical Roots and Current Research DirectionsVeronica M Hong, Avaneesh Rade, Amulya Bhaskara, et al.ACS Pharmacology & Translational Science|July 17, 2025
Saliva-Activated Nanohybrid Aggregates Are Rapid-Acting Agglutination Agents with Potent Anticaries Activity and Limited ToxicityKassapa Ellepola, Mohamad Khalid Alhadlaq, Angeliki Andrianopoulou, et al.ACS Pharmacology & Translational Science|July 17, 2025
Targeting of a Bile Acid Receptor, Takeda G Protein Receptor 5 [TGR5], by a Novel First-in-Class Competitive Antagonist, SBI-364, Diminishes Hepatic and Renal Cystogenesis in Polycystic Liver and Kidney DiseaseTetyana Masyuk, Anatoliy Masyuk, Christy Trussoni, et al.ACS Pharmacology & Translational Science|July 17, 2025
Targeting Casein Kinase 2 and Histone Deacetylase with a Dual Inhibitor Effectively Reduces Tumor Growth in a Triple-Negative Breast Cancer Xenograft ModelIrene Ortín, Laura Ochoa-Callejero, Christian Werner, et al.Pageof 139